The Latest Cardiac and Vascular News
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today the full market release of the 2.00 Max Crown for […]
Webcast Scheduled for Tomorrow, August 3, 2022, at 9:00 a.m. CT (10:00 a.m. ET) Revenues of $62.5 million increased 11% sequentially compared to third quarter this year and decreased 12% compared to fourth quarter last year Management provides fiscal 23 […]
Conference Call Scheduled for Today, May 4, 2022, at 8:00 a.m. CT (9:00 a.m. ET) Revenues of $56.2 million decreased 4.9% sequentially compared to second quarter this year and decreased 11.1% compared to third quarter last year Fiscal year 22 […]
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary vascular disease, today announced that it has appointed Jeffery W. Chambers, M.D., as Chief Medical Officer. […]
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patient has been successfully treated with its […]
Conference Call Scheduled for Today, August 4, 2021, at 3:30 PM CT (4:30 PM ET) Revenues of $71.0 million increased 66.8% compared to fourth quarter last year and increased 12.2% sequentially compared to third quarter this year Fiscal 2021 revenues […]
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the full line of OrbusNeich® JADE® percutaneous transluminal angioplasty (PTA) over-the-wire […]
Conference Call Scheduled for Today, May 6, 2021, at 3:30 PM CT (4:30 PM ET) Revenues of $63.3 million increased 3.4% compared to third quarter last year Net loss of $6.0 million includes $3.4 million related to acquisition of peripheral […]
Device offers a streamlined approach for lower extremity embolic protection ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today […]
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patient in Europe has been treated with […]
